stockrowPrivia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) Shares outstanding
Privia Health Group, Inc.'s shares outstanding at the end of fiscal 2025 was $128.9M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $132.7M. Over the past ten years it has ranged from $95.9M (fiscal 2019) to $128.9M (fiscal 2025) — the current reading is the highest in ten years. Privia Health Group, Inc. ranks 10th of 43 Health Information Services companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $128.9M | 2.61% |
| FY2024 | $125.6M | 0.74% |
| FY2023 | $124.7M | 12.64% |
| FY2022 | $110.7M | 7.52% |
| FY2021 | $103.0M | 7.30% |
| FY2020 | $96.0M | 0.02% |
| FY2019 | $95.9M | (9.50%) |
| FY2018 | $106.0M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $132.7M | 0.67% |
| Jun 2026 | $131.8M | 0.72% |
| Mar 2026 | $130.9M | 1.54% |
| Dec 2025 | $128.9M | 0.09% |
| 23 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| GDRX GoodRx Holdings, Inc. compare | $348.1M |
| WAY Waystar Holding Corp. compare | $195.9M |
| DOCS Doximity, Inc. compare | $187.8M |
| TDOC Teladoc Health, Inc. compare | $181.9M |
| CERT Certara, Inc. compare | $152.7M |
| PRVA Privia Health Group, Inc. | $132.7M |
| HTFL Heartflow, Inc. compare | $86.4M |
| SDGR Schrodinger, Inc. compare | $74.9M |
| OMCL Omnicell, Inc. compare | $46.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement